Daratumumab rapidly reduces high-titre factor VIII inhibitors in haemophilia A patients during life-threatening haemorrhages

被引：5

作者：

Moonla, Chatphatai ^{[1
,2
,3
]}

Uaprasert, Noppacharn ^{[1
,2
,3
]}

Watanaboonyongcharoen, Phandee ^{[2
,3
,4
]}

Meesanun, Mukmanee ^{[1
,2
,3
]}

Sukperm, Autcharaporn ^{[1
,2
,3
]}

Jantasing, Ratchaneekorn ^{[1
,2
,3
]}

Faknuam, Saruta ^{[2
,5
]}

Chanswangphuwana, Chantiya ^{[1
,2
,3
]}

Polprasert, Chantana ^{[1
,2
,3
]}

Sodsai, Pimpayao ^{[2
,6
]}

Akkawat, Benjaporn ^{[1
,2
,3
]}

Hirankarn, Nattiya ^{[2
,6
]}

Bunworasate, Udomsak ^{[1
,2
,3
]}

Rojnuckarin, Ponlapat ^{[1
,2
,3
]}

机构：

[1] Chulalongkorn Univ, Dept Med, Fac Med, Rama IV Rd, Bangkok 10330, Thailand

[2] King Chulalongkorn Mem Hosp, Rama IV Rd, Bangkok 10330, Thailand

[3] Chulalongkorn Univ, Res Unit Translat Hematol, Fac Med, Bangkok, Thailand

[4] Chulalongkorn Univ, Dept Lab Med, Fac Med, Bangkok, Thailand

[5] Nakhon Pathom Hosp, Dept Med, Nakhon Pathom, Thailand

[6] Chulalongkorn Univ, Ctr Excellence Immunol & Immune Mediated Dis, Dept Microbiol, Fac Med, Bangkok, Thailand

来源：

HAEMOPHILIA | 2021年 / 27卷 / 01期

关键词：

IMMUNE TOLERANCE; INDUCTION; ANTIBODIES; CELLS; IGG;

D O I：

10.1111/hae.14118

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E155 / E159

页数：5

共 14 条

[1] Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study [J].

Antun, A. ;

Monahan, P. E. ;

Manco-Johnson, M. J. ;

Callaghan, M. U. ;

Kanin, M. ;

Knoll, C. ;

Carpenter, S. L. ;

Davis, J. A. ;

Guerrera, M. F. ;

Kruse-Jarres, R. ;

Ragni, M. V. ;

Witmer, C. ;

McCracken, C. E. ;

Kempton, C. L. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (11) :1980-1988

[2] Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice [J].

DiLillo, David J. ;

Hamaguchi, Yasuhito ;

Ueda, Yoshihiro ;

Yang, Kaiyong ;

Uchida, Junji ;

Haas, Karen M. ;

Kelsoe, Garnett ;

Tedder, Thomas F. .

JOURNAL OF IMMUNOLOGY, 2008, 180 (01) :361-371

[3] Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients [J].

Frerichs, Kristine A. ;

Bosman, Patricia W. C. ;

van Velzen, Jeroen F. ;

Fraaij, Pieter L. A. ;

Koopmans, Marion P. G. ;

Rimmelzwaan, Guus F. ;

Nijhof, Inger S. ;

Bloem, Andries C. ;

Mutis, Tuna ;

Zweegman, Sonja ;

van de Donk, Niels W. C. J. .

HAEMATOLOGICA, 2020, 105 (06) :E302-E306

[4] The principal results of the International Immune Tolerance Study: a randomized dose comparison [J].

Hay, Charles R. M. ;

DiMichele, Donna M. .

BLOOD, 2012, 119 (06) :1335-1344

[5] Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma [J].

Krejcik, Jakub ;

Casneuf, Tineke ;

Nijhof, Inger S. ;

Verbist, Bie ;

Bald, Jaime ;

Plesner, Torben ;

Syed, Khaja ;

Liu, Kevin ;

van de Donk, Niels W. C. J. ;

Weiss, Brendan M. ;

Ahmadi, Tahamtan ;

Lokhorst, Henk M. ;

Mutis, Tuna ;

Sasser, A. Kate .

BLOOD, 2016, 128 (03) :384-394

[6] Rituximab for treatment of inhibitors in haemophilia A A Phase II Study [J].

Leissinger, Cindy ;

Josephson, Cassandra D. ;

Granger, Suzanne ;

Konkle, Barbara A. ;

Kruse-Jarres, Rebecca ;

Ragni, Margaret V. ;

Journeycake, Janna M. ;

Valentino, Leonard ;

Key, Nigel S. ;

Gill, Joan C. ;

McCrae, Keith R. ;

Neufeld, Ellis J. ;

Manno, Catherine ;

Raffini, Leslie ;

Saxena, Kapil ;

Torres, Marcela ;

Marder, Victor ;

Bennett, Carolyn M. ;

Assmann, Susan F. .

THROMBOSIS AND HAEMOSTASIS, 2014, 112 (03) :445-458

[7] Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial [J].

Lonial, Sagar ;

Weiss, Brendan M. ;

Usmani, Saad Z. ;

Singhal, Seema ;

Chari, Ajai ;

Bahlis, Nizar J. ;

Belch, Andrew ;

Krishnan, Amrita ;

Vescio, Robert A. ;

Victoria Mateos, Maria ;

Mazumder, Amitabha ;

Orlowski, Robert Z. ;

Sutherland, Heather J. ;

Blade, Joan ;

Scott, Emma C. ;

Oriol, Albert ;

Berdeja, Jesus ;

Gharibo, Mecide ;

Stevens, Don A. ;

LeBlanc, Richard ;

Sebag, Michael ;

Callander, Natalie ;

Jakubowiak, Andrzej ;

White, Darrell ;

de la Rubia, Javier ;

Richardson, Paul G. ;

Lisby, Steen ;

Feng, Huaibao ;

Uhlar, Clarissa M. ;

Khan, Imran ;

Ahmadi, Tahamtan ;

Voorhees, Peter M. .

LANCET, 2016, 387 (10027) :1551-1560

[8] Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells [J].

Meslier, Y. ;

Andre, S. ;

Dimitrov, J. D. ;

Delignat, S. ;

Bayry, J. ;

Kaveri, S. V. ;

Lacroix-Desmazes, S. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (04) :719-728

[9] Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance [J].

Miller, C. H. ;

Platt, S. J. ;

Rice, A. S. ;

Kelly, F. ;

Soucie, J. M. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) :1055-1061

[10] INDUCTION OF IMMUNE TOLERANCE IN PATIENTS WITH HEMOPHILIA AND ANTIBODIES TO FACTOR-VIII BY COMBINED TREATMENT WITH INTRAVENOUS IGG, CYCLOPHOSPHAMIDE, AND FACTOR-VIII [J].

NILSSON, IM ;

BERNTORP, E ;

ZETTERVALL, O .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (15) :947-950

← 1 2 →